1–5 of 5 results for ellipsoid zone
Post Hoc Analyses of Responder Status in Phase 3 Studies of Ciliary Neurotrophic Factor-Producing Revakinagene Taroretcel in People With Macular Telangiectasia Type 2
John A. Wells, MD, FACS
Annual Meeting Talks
2024
Baseline Ellipsoid Zone Integrity Features as Predictors of Geographic Atrophy Growth Rate in the Phase 3 GATHER Clinical Trials
Katherine E Talcott, MD
Post Hoc Analyses of Responder Status in Phase 3 Studies of Ciliary Neurotrophic Factor–Producing Revakinagene Taroretcel in People With Macular Telangiectasia Type 2
Updates from the Field
VISTA-DME Study Insights in Ellipsoid Zone Dynamics and Retinal Fluid Index
Ronald W Milam, MD
On Demand Cases, Courses, and Papers
2019
Longitudinal Ellipsoid Zone Mapping on Spectral Domain OCT in Eyes With Hydroxychloroquine Use to Evaluate for Subclinical Outer Retinal Alterations